An initial study last year raised similar concerns in the same kinds of patients.
Pfizer said a clinical study involving more than 1,500 patients showed that those who had undergone bypass surgery and had taken Bextra and were at higher risk for heart attacks.
Pfizer Inc. warned doctors on Friday that one of its bestselling painkillers, Bextra, might increase the risk of a heart attack or stroke in coronary artery bypass surgery patients.
The painkillers known as COX-2 inhibitors have been prescribed to people suffering with arthritis.
